MarginsXMarginsX
Home › Markets › Miscellaneous › CUVL

Clinuvel Pharmaceuticals Limited (CUVL)

CUVL trades on Nasdaq in Miscellaneous, Miscellaneous. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$4.98
-2.54% on the day
Market cap
$251.1M
Micro cap
Revenue · 2026
$64.3M
+5.2% on 2025
Net income · 2026
$23.2M
36.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-06-30, https://www.sec.gov/Archives/edgar/data/1290877/000149315226049364/0001493152-26-049364-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), fiscal year ended 2026-06-30.

Profile

FieldValue
TickerCUVL on Nasdaq
SectorMiscellaneous
IndustryMiscellaneous
CountryAustralia
IPO yearNot reported by the screener
SEC CIK0001290877
SEC industry codeAmerican Depositary Receipts
Incorporated inAustralia

Financials · 2026

LineValue
Revenue$64.3M
Net income$23.2M
Operating income$27.9M
Net margin36.0%
Operating margin43.4%
Revenue growth+5.2%
Cash$13.9M
Total assets$204.0M
P/E (computed)10.8×
P/S (computed)3.9×

Warning signs

Cash runway
Cash-flow positive
$13.9M cash at June 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
20-F filed October 30, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-10-30
Cash and burn$13.9M cash; operating cash flow $3.2M a quarter.Report 2026-06-30
Shares outstanding50,427,898 (2026-06-30).Cover page 2026-06-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorGrant Thornton Audit Pty Ltd, Melbourne, AustraliaPCAOB Form AP 2026-07-08
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2026
2026-06-30
$64.3M$23.2M$12.9M$13.9MNo debt tags$64.3M20-F 2026-10-30
FY 2025
2025-06-30
$61.1M$23.1M$27.3M$18.1MNo debt tags$61.1M20-F 2026-10-30
FY 2024
2024-06-30
$57.9M$23.3M$23.8MNot filedNo debt tags$57.9M20-F 2026-10-30

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-07-17
Latest annual report20-F2026-10-30
Latest quarterly / interim6-K2026-10-30

Source: SEC EDGAR submissions feed, 49 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.0%
1 month-7.2%
3 months-25.0%
Year to date-40.4%
1 year-28.9%
From 52-week high-42.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Miscellaneous

TickerCompanyPriceDayMarket cap
CDTGCDT Environmental Technology Investment Holdings Limited$1.04-0.48%$3.1M
DXSTDecent Holding Inc$0.7010+0.10%$1.5M
FERGFerguson Enterprises Inc.$253.20-1.27%$49.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier